Table 5.
Concordance of MDT and CDT recommendations per tumor type and stage
| Concordant cases, n (%) | Non-concordant cases, n (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Total | Concordant cases | Conditional concordant | Total | Motivated | Not motivated | Distribution per tumor stage in research sample in percentages | Distribution per tumor stage in the Netherlands in percentages | |
| Breast cancer cases (n = 102) | 96 (94.1) | 87 (85.3) | 9 (8.8) | 6 (5,9) | 2 (2.0) | 4 (3.9) | Incidences 2018a | |
| TNM stage 0 | 17 | 0 | 0 | 0 | 17 | 12 | ||
| I | 36 | 2 | 0 | 3 | 40 | 41 | ||
| II | 28 | 5 | 2 | 1 | 35 | 33 | ||
| III | 5 | 2 | 0 | 0 | 7 | 9 | ||
| IV | 1 | 0 | 0 | 0 | 1 | 5 | ||
| Colorectal cancer cases (n = 90) | 85 (94.4) | 80 (88.9) | 5 (5.6) | 5 (5.6) | 4 (4.4) | 1 (1.1) | Incidences 2017a | |
| TNM stage 0 | NA | NA | NA | NA | NA | NA | ||
| I | 22 | 0 | 0 | 0 | 24 | 26 | ||
| II | 13 | 1 | 0 | 1 | 17 | 23 | ||
| III | 7 | 3 | 0 | 0 | 11 | 28 | ||
| IV | 38 | 1 | 4 | 0 | 48 | 20 | ||
| Prostate cancer cases (n = 104) | 92 (88.5) | 82 (78.8) | 10 (9.6) | 12 (11.5) | 10 (9.6) | 2 (1.9) | Incidences 2016a | |
| TNM stage 0 | NA | NA | NA | NA | NA | NA | ||
| I | 14 | 0 | 1 | 0 | 14 | 38 | ||
| II | 18 | 1 | 0 | 0 | 18 | 20 | ||
| III | 10 | 1 | 0 | 0 | 11 | 17 | ||
| IV | 40 | 8 | 9 | 2 | 57 | 25 | ||
| Total (n = 296) | 273 (92.2) | 249 (84.1) | 24 (8.1) | 23 (7.8) | 16 (5.4) | 7 (2.4) | ||
MDT: multidisciplinary team; CPG: clinical practice guideline; CDT: clinical decision tree; NA: not applicable.
a
The most recent complete years per tumor type were retrieved from the Netherlands Cancer Registry.